Group 5F: HR+ Breast Cancer; Clinical Trials; Hormone Therapies; Targeted Therapies; Treatment Resistance
Thursday, June 15
2:00 pm – 3:30 pm Eastern Time (US/New York)
Mentor: Stephanie Walker, R.N.
Stephanie Walker was diagnosed in July 2015 with de novo MBC. A retired RN with close to 40 years of clinical practice and 3 years teaching in a Community College. Her experience has been pediatric and adult critical care working in level 1 trauma centers and critical access hospitals. The last 15 years of her nursing career were with Hospice care. She is a member of many organizations, local- and national-based, and a recipient of the Spirit to Impact award. She is also project lead on an initiative called BECOME (Black Experience of Clinical Trials and Opportunities of Meaningful Engagement), as part of the MBC Alliance. She is advocating for men and women in rural areas for equal access to quality healthcare, treatment modalities, and resources. She does not want anyone to feel alone, isolated, or defeated.
Scientist: Vinton Cheng, M.D., Ph.D.
Vinton Cheng is an academic clinical lecturer at the University of Leeds and St James’s University Hospital, UK. He completed his DPhil at the University of Oxford, where he studied a molecularly targeted MRI contrast agent that was shown to improve detection of brain metastasis. Vinton enjoys working at the interface of different research disciplines and most recently spent a year working in the Focused Ultrasound group at the University of Virginia investigating how to enhance the immune response against brain metastasis. He is passionate about communicating science and collaborating with patients in the clinic to improve cancer care.